This story has been updated to provide comments from Trovagene's management made during a conference call with investors.

NEW YORK (GenomeWeb) – Trovagene reported after the close of the market on Thursday that its fourth quarter revenues rose 41 percent year over year.

The liquid biopsy MDx developer said its revenues rose to $79,000 for the three months ended Dec. 31, 2015, up from $56,000 in Q4 2014. However, the revenues significantly missed analysts' estimates of $100,000 for the quarter.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Sequencing could help combat foodborne illnesses, according to a blog post by Food and Drug Administration officials.

Popular Mechanics reports that Caltech researchers have built a prototype nanobot using DNA.

The Sacramento Bee writes that direct-to-consumer genetic testing connected a woman to sperm donor-conceived half siblings.

In PLOS this week: gene expression catalog for sheep, viral diversity among respiratory samples from camels, and more.